U.S. Panel Probes Marketing of Wyeth Transplant Drug, Rapamune

Reuters -- A U.S. House of Representatives committee is investigating reports that drugmaker Wyeth, now a unit of Pfizer Inc (PFE.N), promoted a transplant drug to African-Americans for unapproved uses, the panel’s chairman said on Friday.